+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Product Type (Instruments, Reagents & Kits, Software And Services), Sample Type, Technology, Disease Type, End User - Global Forecast 2025-2030- Product Image
Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Product Type (Instruments, Reagents & Kits, Software And Services), Sample Type, Technology, Disease Type, End User - Global Forecast 2025-2030- Product Image
Sale

Endocrine Testing Market by Type (Cortisol Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Estradiol (E2) Test), Product Type (Instruments, Reagents & Kits, Software And Services), Sample Type, Technology, Disease Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887503
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in healthcare diagnostics face an evolving endocrine testing market shaped by technological advances, regulatory shifts, and changing patient expectations. Actionable market intelligence is necessary for those seeking to align their strategies with new growth opportunities and manage ongoing industry transitions.

Market Snapshot: Endocrine Testing Market Size and Trajectory

The Endocrine Testing Market grew from USD 10.07 billion in 2024 to USD 10.88 billion in 2025. It is expected to continue growing at a CAGR of 8.33%, reaching USD 16.29 billion by 2030. This growth underscores rising demand for precision diagnostics supporting metabolic, reproductive, and thyroid disorders. Stakeholders across diagnostic laboratories, hospitals, and technology providers recognize the expanding role of hormonal analysis in proactive disease management and patient-centric care.

Scope & Segmentation: Comprehensive Coverage of the Endocrine Testing Market

This report delivers a granular breakdown across the industry, enabling effective strategic planning and investment targeting. Analysis covers the following segments and variables:

  • Type: Cortisol tests, dehydroepiandrosterone sulfate (DHEAS) tests, estradiol (E2) tests, human chorionic gonadotropin (hCG) hormone tests, insulin tests, sex hormone tests, and thyroid stimulating hormone (TSH) tests.
  • Product Type: Chromatography systems, immunoassay analyzers, mass spectrometry systems, calibrators, control materials, diagnostic kits, informatics solutions, and maintenance services.
  • Sample Type: Blood, saliva, and urine.
  • Technology: Clinical chemistry, immunoassay, monoclonal and polyclonal antibody technologies, sensor technology, tandem mass spectrometry.
  • Disease Type: Adrenal disorders (including Addison's disease and Cushing's syndrome), diabetes, gonadal disorders (such as hypogonadism and polycystic ovary syndrome), thyroid dysfunction (hyperthyroidism and hypothyroidism).
  • End User: Academic institutions, diagnostic laboratories, hospitals and clinics, research institutes.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Italy, UAE, Saudi Arabia, South Africa, and other key countries), and Asia-Pacific (China, India, Japan, South Korea, Australia, Southeast Asia states).
  • Company Analysis: Assessment includes Bio-Rad Laboratories Inc, bioMérieux SA, Abbott Laboratories, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, and additional global and regional participants.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Integrated platforms are gaining traction, offering comprehensive hormone panels in a single workflow and improving diagnostic efficiency across care settings.
  • Point-of-care testing and cloud-connected devices are expanding the reach of endocrine diagnostics, enabling near-patient and remote assessments that support clinical decision-making outside central labs.
  • Advancements in mass spectrometry and immunoassay technology have increased test precision, reduced turnaround times, and supported the growing demand for multiplexed biomarker monitoring.
  • Patient-centered innovations, including minimally invasive saliva and urine collection technologies, are enhancing test accessibility while maintaining clinical rigor.
  • Shifting reimbursement models and evolving quality standards in both established and emerging markets drive ongoing investments in accredited platforms and regulatory engagement.
  • Collaborations among diagnostic providers, academic institutions, and technology developers are accelerating translational research and enabling the co-development of targeted assay solutions.

Tariff Impact: Navigating the Effects of U.S. Trade Measures

The introduction of new United States tariff measures in 2025 presents challenges to cost structures for manufacturers and distributors of endocrine testing instruments, reagents, and digital services. Companies are responding with supply chain realignment, prioritizing domestic sourcing where possible, and renegotiating supply contracts to manage price volatility. These adjustments are being complemented by the adoption of flexible pricing models within software and maintenance service segments, preserving competitive positioning and ensuring continuity for laboratory customers.

Methodology & Data Sources

The report employs a structured methodology, combining in-depth secondary research from peer-reviewed journals and patent filings with interviews of endocrinologists, laboratory executives, and industry specialists. This approach is supplemented by quantitative modeling, regional data mapping, and validation through expert peer review, ensuring robust and relevant insights.

Why This Report Matters: Informed Decisions for Market Leadership

  • Senior leaders gain clarity on opportunities and challenges emerging from new testing technologies, evolving care models, and international regulatory trends.
  • Actionable analysis supports effective resource allocation and risk mitigation in response to tariff policy changes and market expansion drivers.
  • Comprehensive segmentation, competitor profiling, and regional dynamics empower stakeholders to identify high-growth areas and optimize strategic initiatives for sustained market advantage.

Conclusion

This report positions industry leaders to act with confidence as the endocrine testing market evolves. By leveraging evidence-based intelligence, decision-makers can target innovation, partnerships, and operational improvements for long-term success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased awareness of the importance of early detection of endocrine disorders
5.2. Growing adoption of point-of-care testing devices
5.3. Rising demand for personalized medicine approaches driving tailored endocrine therapies
5.4. Integration of artificial intelligence algorithms in endocrine assay interpretation for enhanced diagnostic precision
5.5. Adoption of multiplexed immunoassay platforms for simultaneous screening of multiple hormone biomarkers
5.6. Emergence of home-based endocrine testing kits enabling continuous hormonal monitoring outside clinical settings
5.7. Development of ultra-sensitive mass spectrometry methods for low-abundance hormone quantification in complex matrices
5.8. Expansion of companion diagnostics in oncology revealing endocrine markers predictive of treatment response
5.9. Enhanced regulatory focus on assay standardization and quality control to improve test reliability
5.10. Increasing investment in wearable biosensors for real-time hormonal monitoring and health management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Endocrine Testing Market, by Type
8.1. Introduction
8.2. Cortisol Test
8.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
8.4. Estradiol (E2) Test
8.5. Human Chorionic Gonadotropin (hCG) Hormone Test
8.6. Insulin Test
8.7. Sex Hormone Tests
8.8. Thyroid Stimulating Hormone (TSH) Test
9. Endocrine Testing Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Chromatography Systems
9.2.2. Immunoassay Analyzers
9.2.3. Mass Spectrometry Systems
9.3. Reagents & Kits
9.3.1. Calibrators
9.3.2. Control Materials
9.3.3. Diagnostic Kits
9.4. Software And Services
9.4.1. Informatics Solutions
9.4.2. Maintenance Services
10. Endocrine Testing Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Saliva
10.4. Urine
11. Endocrine Testing Market, by Technology
11.1. Introduction
11.2. Clinical Chemistry
11.3. Immunoassay
11.4. Monoclonal & Polyclonal Antibody Technologies
11.5. Sensor Technology
11.6. Tandem Mass Spectrometry
12. Endocrine Testing Market, by Disease Type
12.1. Introduction
12.2. Adrenal Disorders
12.2.1. Addison's Disease
12.2.2. Cushing's Syndrome
12.3. Diabetes
12.4. Gonadal Disorders
12.4.1. Hypogonadism
12.4.2. Polycystic Ovary Syndrome
12.5. Thyroid Dysfunction
12.5.1. Hyperthyroidism
12.5.2. Hypothyroidism
13. Endocrine Testing Market, by End User
13.1. Introduction
13.2. Academic Institutions
13.3. Diagnostic Laboratories
13.4. Hospitals & Clinics
13.5. Research Institutes
14. Americas Endocrine Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Endocrine Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Endocrine Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bio-Rad Laboratories Inc
17.3.2. bioMérieux SA
17.3.3. Abbott Laboratories
17.3.4. ACON Laboratories, Inc.
17.3.5. Agilent Technologies, Inc.
17.3.6. BioCheck Inc.
17.3.7. Biogenix Inc. Pvt. Ltd
17.3.8. Blueprint Genetics Oy
17.3.9. Creative Diagnostics
17.3.10. Danaher Corporation
17.3.11. Diagnostic Automation/Cortez Diagnostics Inc.
17.3.12. DiaSorin S.p.A.
17.3.13. Eagle Biosciences
17.3.14. EKF Diagnostics Holdings Plc
17.3.15. Eurofins Analytical Laboratories Inc.
17.3.16. Getein Biotech, Inc.
17.3.17. Laboratory Corporation of America Holdings
17.3.18. MP Biomedicals, LLC
17.3.19. Ortho-Clinical Diagnostics, Inc.
17.3.20. Quest Diagnostics Incorporated
17.3.21. Randox Laboratories Ltd.
17.3.22. Shenzhen New Industries Biomedical Engineering Co., Ltd.
17.3.23. Siemens Healthcare GmbH
17.3.24. Thermo Fisher Scientific Inc.
17.3.25. Trivitron Healthcare
17.3.26. Eli Science Inc.
17.3.27. F. Hoffmann-La Roche Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ENDOCRINE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ENDOCRINE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ENDOCRINE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ENDOCRINE TESTING MARKET: RESEARCHAI
FIGURE 28. ENDOCRINE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. ENDOCRINE TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. ENDOCRINE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENDOCRINE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENDOCRINE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CORTISOL TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DEHYDROEPIANDROSTERONE SULFATE (DHEAS) TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ESTRADIOL (E2) TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSULIN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SEX HORMONE TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID STIMULATING HORMONE (TSH) TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MASS SPECTROMETRY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CALIBRATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CONTROL MATERIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY INFORMATICS SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY MONOCLONAL & POLYCLONAL ANTIBODY TECHNOLOGIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY SENSOR TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADDISON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY CUSHING'S SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOGONADISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ENDOCRINE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ENDOCRINE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. CANADA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. CANADA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. CANADA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 172. CANADA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 173. CANADA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 174. CANADA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 175. CANADA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 177. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. CANADA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. CANADA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 182. CANADA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 183. CANADA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 184. CANADA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 185. CANADA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 186. CANADA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 187. CANADA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA ENDOCRINE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. GERMANY ENDOCRINE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 316. GERMANY ENDOCRINE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 317. GERMANY ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY ENDOCRINE TESTING MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 319. GERMANY ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 320. GERMANY ENDOCRINE TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 321. GERMANY ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 322. GERMANY ENDOCRINE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 323. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 324. GERMANY ENDOCRINE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 325. GERMANY ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 326. GERMANY ENDOCRINE TESTING MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 327. GERMANY ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 328. GERMANY ENDOCRINE TESTING MARKET SIZE, BY ADRENAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 329. GERMANY ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2018-2024 (USD MILLION)
TABLE 330. GERMANY ENDOCRINE TESTING MARKET SIZE, BY GONADAL DISORDERS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2018-2024 (USD MILLION)
TABLE 332. GERMANY ENDOCRINE TESTING MARKET SIZE, BY THYROID DYSFUNCTION, 2025-2030 (USD MILLION)
TABLE 333. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. GERMANY ENDOCRINE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 336. FRANCE ENDOCRINE TESTING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Endocrine Testing market report include:
  • Bio-Rad Laboratories Inc
  • bioMérieux SA
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • BioCheck Inc.
  • Biogenix Inc. Pvt. Ltd
  • Blueprint Genetics Oy
  • Creative Diagnostics
  • Danaher Corporation
  • Diagnostic Automation/Cortez Diagnostics Inc.
  • DiaSorin S.p.A.
  • Eagle Biosciences
  • EKF Diagnostics Holdings Plc
  • Eurofins Analytical Laboratories Inc.
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • MP Biomedicals, LLC
  • Ortho-Clinical Diagnostics, Inc.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare
  • Eli Science Inc.
  • F. Hoffmann-La Roche Ltd

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.29 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Endocrine Testing - Global Strategic Business Report - Product Image

Endocrine Testing - Global Strategic Business Report

  • Report
  • 168 Pages
  • Global
From
Endocrine Testing Market Report 2025 - Product Image

Endocrine Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2024-2028 Global Cortisol Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Cortisol Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
Endocrine Peptide Test Market Report 2025 - Product Image

Endocrine Peptide Test Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Quick Guide to Endocrinology. The Pediatric Version. Edition No. 2 - Product Image

Quick Guide to Endocrinology. The Pediatric Version. Edition No. 2

  • Book

About the Endocrine Testing Market

The Endocrine Testing market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to diagnose and monitor endocrine disorders, such as diabetes, thyroid disorders, and adrenal disorders. Endocrine testing is used to measure the levels of hormones in the body, such as insulin, cortisol, and testosterone. It is also used to diagnose and monitor diseases such as Cushing's syndrome, Addison's disease, and hyperthyroidism. Endocrine testing is used to diagnose and monitor a variety of conditions, including infertility, obesity, and metabolic disorders. Endocrine testing is a critical component of IVD, as it helps to diagnose and monitor endocrine disorders. Endocrine testing is used in both clinical and research settings, and is used to diagnose and monitor a variety of conditions. Some companies in the Endocrine Testing market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.